The first drug approved to treat Covid-19 in Japan was not a drug manufactured by Fujifilm.
By combining three different drugs, the trial of Hong Kong doctors showed that the duration of Covid-19 treatment was reduced by almost half.
The National Institutes of Health on February 25 confirmed that the first clinical trial in the US for a new strain of corona virus treatment has begun at the University of
Chinese researchers found that the three current drugs have a fairly good inhibitory effect on the new corona virus (2019-nCoV) at the cellular level, Xinhua reported on January
EB3, a drug that helps reduce the Ebola mortality rate to only 6%.